Double-Barreled immunotherapy aims to wipe out hidden myeloma cells
Disease control
Recruiting now
This study tests whether a two-step immunotherapy approach can eliminate remaining cancer cells in people with newly diagnosed multiple myeloma who still have detectable disease after initial treatment. Participants first receive talquetamab, and if that doesn't clear the cancer,…
Phase: PHASE2 • Sponsor: Noffar Bar • Aim: Disease control
Last updated May 14, 2026 12:05 UTC